Figure 4.
PFS of patients stratified by (a) line of treatment where CDK4/6i was used, (b) presence of liver metastasis, (c) age and (d) starting dose of CDK4/6i.
CDK4/6i, cyclin-dependent kinase 4/6 inhibitor; PFS, progression-free survival.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.